1. Home
  2. PHAT vs METC Comparison

PHAT vs METC Comparison

Compare PHAT & METC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAT
  • METC
  • Stock Information
  • Founded
  • PHAT 2018
  • METC 2015
  • Country
  • PHAT United States
  • METC United States
  • Employees
  • PHAT N/A
  • METC N/A
  • Industry
  • PHAT Biotechnology: Pharmaceutical Preparations
  • METC Coal Mining
  • Sector
  • PHAT Health Care
  • METC Energy
  • Exchange
  • PHAT Nasdaq
  • METC Nasdaq
  • Market Cap
  • PHAT 423.4M
  • METC 480.1M
  • IPO Year
  • PHAT 2019
  • METC 2017
  • Fundamental
  • Price
  • PHAT $5.12
  • METC $8.50
  • Analyst Decision
  • PHAT Strong Buy
  • METC Strong Buy
  • Analyst Count
  • PHAT 4
  • METC 3
  • Target Price
  • PHAT $23.00
  • METC $17.00
  • AVG Volume (30 Days)
  • PHAT 1.5M
  • METC 963.3K
  • Earning Date
  • PHAT 03-06-2025
  • METC 05-07-2025
  • Dividend Yield
  • PHAT N/A
  • METC 5.68%
  • EPS Growth
  • PHAT N/A
  • METC N/A
  • EPS
  • PHAT N/A
  • METC 0.21
  • Revenue
  • PHAT $55,252,000.00
  • METC $666,295,000.00
  • Revenue This Year
  • PHAT $202.16
  • METC $12.66
  • Revenue Next Year
  • PHAT $113.86
  • METC $17.56
  • P/E Ratio
  • PHAT N/A
  • METC $40.58
  • Revenue Growth
  • PHAT 8001.47
  • METC N/A
  • 52 Week Low
  • PHAT $4.07
  • METC $7.87
  • 52 Week High
  • PHAT $19.71
  • METC $16.58
  • Technical
  • Relative Strength Index (RSI)
  • PHAT 41.95
  • METC 45.14
  • Support Level
  • PHAT $6.03
  • METC $7.87
  • Resistance Level
  • PHAT $6.89
  • METC $9.27
  • Average True Range (ATR)
  • PHAT 0.58
  • METC 0.51
  • MACD
  • PHAT 0.05
  • METC -0.07
  • Stochastic Oscillator
  • PHAT 37.23
  • METC 33.51

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

About METC Ramaco Resources Inc.

Ramaco Resources Inc is a United States-based company that operates as a pure-play metallurgical coal company with operations in southern West Virginia and southwestern Virginia. Its portfolio includes high-quality metallurgical coal reserves and resources, with a focus on properties such as Elk Creek, Berwind, Knox Creek, and Maben. These properties are strategically located to serve North American blast furnace steel mill and coke plants, as well as international metallurgical coal consumers. Additionally, the company controls mineral deposits in Sheridan, Wyoming, exploring potential opportunities in rare earth elements and coal-to-carbon-based products. Operations are concentrated in the Appalachian basin, with active mines at Elk Creek, Berwind, Knox Creek, and Maben mining complexes.

Share on Social Networks: